SG Americas Securities LLC Raises Position in Cigna Group $CI

SG Americas Securities LLC increased its holdings in Cigna Group (NYSE:CIFree Report) by 6,060.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 322,488 shares of the health services provider’s stock after purchasing an additional 317,253 shares during the period. SG Americas Securities LLC owned 0.12% of Cigna Group worth $88,758,000 as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in CI. Brighton Jones LLC boosted its stake in Cigna Group by 9.3% in the 4th quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider’s stock worth $1,032,000 after buying an additional 318 shares during the last quarter. Sivia Capital Partners LLC increased its stake in shares of Cigna Group by 10.4% during the 2nd quarter. Sivia Capital Partners LLC now owns 1,160 shares of the health services provider’s stock valued at $384,000 after acquiring an additional 109 shares during the last quarter. Magnetar Financial LLC acquired a new position in shares of Cigna Group during the 2nd quarter valued at about $724,000. Charles Schwab Investment Management Inc. lifted its holdings in shares of Cigna Group by 0.7% during the 2nd quarter. Charles Schwab Investment Management Inc. now owns 2,052,912 shares of the health services provider’s stock worth $678,652,000 after acquiring an additional 15,014 shares during the period. Finally, Coldstream Capital Management Inc. lifted its holdings in shares of Cigna Group by 3.5% during the 2nd quarter. Coldstream Capital Management Inc. now owns 6,208 shares of the health services provider’s stock worth $2,052,000 after acquiring an additional 208 shares during the period. 86.99% of the stock is currently owned by institutional investors and hedge funds.

Cigna Group Trading Down 0.4%

NYSE CI opened at $261.77 on Tuesday. The firm has a market capitalization of $68.98 billion, a price-to-earnings ratio of 11.80, a PEG ratio of 0.91 and a beta of 0.27. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.74 and a current ratio of 0.74. Cigna Group has a one year low of $239.51 and a one year high of $350.00. The company’s 50 day moving average price is $277.58 and its 200 day moving average price is $281.15.

Cigna Group (NYSE:CIGet Free Report) last released its quarterly earnings data on Thursday, February 5th. The health services provider reported $8.08 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.88 by $0.20. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The company had revenue of $72.50 billion during the quarter, compared to the consensus estimate of $69.53 billion. During the same period in the previous year, the firm earned $6.64 earnings per share. Cigna Group’s revenue for the quarter was up 10.4% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.250- EPS. On average, sell-side analysts predict that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, March 19th. Investors of record on Thursday, March 5th were issued a $1.56 dividend. The ex-dividend date was Thursday, March 5th. This represents a $6.24 annualized dividend and a yield of 2.4%. This is an increase from Cigna Group’s previous quarterly dividend of $1.51. Cigna Group’s payout ratio is currently 28.13%.

Insider Activity

In other Cigna Group news, insider Everett Neville sold 1,719 shares of the firm’s stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $496,636.29. Following the transaction, the insider directly owned 5,670 shares of the company’s stock, valued at $1,638,119.70. This trade represents a 23.26% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Nicole S. Jones sold 2,307 shares of the company’s stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $666,515.37. Following the completion of the sale, the insider directly owned 32,647 shares of the company’s stock, valued at $9,432,044.77. The trade was a 6.60% decrease in their position. The disclosure for this sale is available in the SEC filing. Company insiders own 0.60% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts recently issued reports on CI shares. Sanford C. Bernstein upgraded shares of Cigna Group from a “market perform” rating to an “outperform” rating and boosted their target price for the company from $307.00 to $358.00 in a report on Thursday, March 12th. TD Cowen increased their price target on shares of Cigna Group from $333.00 to $338.00 and gave the stock a “buy” rating in a research note on Monday, February 9th. Royal Bank Of Canada lowered their price objective on shares of Cigna Group from $344.00 to $333.00 and set an “outperform” rating for the company in a research note on Friday, February 6th. Zacks Research upgraded Cigna Group from a “strong sell” rating to a “hold” rating in a report on Monday, January 5th. Finally, Leerink Partners increased their target price on Cigna Group from $270.00 to $297.00 and gave the stock a “market perform” rating in a research report on Friday, February 6th. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and four have given a Hold rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $333.11.

Get Our Latest Stock Analysis on Cigna Group

About Cigna Group

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Featured Articles

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.